ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs

July 7, 1978

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992